spacer
home > ebr > spring 2019 > jewel biomarkers can be found by digging in the right mine
PUBLICATIONS
European Biopharmaceutical Review

Jewel Biomarkers Can Be Found By Digging in the Right Mine

Biomarkers can be fantastic diagnostic tools, especially for rare diseases (1:2,000 up to about 1:100,000) for which an accurate identification may even be lifesaving if identified early on. Literature and experts see biomarkers as cornerstones for the development of new therapeutic approaches.

The EMA and FDA are proponents of seeing the therapeutic effects achieved through biomarker-based ‘theragnostic’. Historically, surrogate biomarkers were accepted in the past (for example, haemoglobin A1c for diabetes). Nowadays, however, biomarkers closely linked to a sickness and potential therapeutic intervention are even more welcome.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Hermann Mascher, Bioanalytical Consultant and founder of pharm-analyt Labor, has more than 100 publications in peer-reviewed journals (and more than 230 cumulative impact factor). He is the inventor of three patents for biomarkers in the area of rare LSDs (Gaucher, NP-C, and metachromatic leukodystrophy) which could be sold.
spacer
Professor Hermann Mascher
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement